Physician profile
Robert L Moore
NPI 1487618674
$4,375.64
in general payments reported to CMS, 2019-2025
22 companies · $559 in 2025
The $559 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $208 · 2021: $640 · 2022: $696 · 2023: $943 · 2024: $600 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,938 · Entertainment: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,938.05 |
| Entertainment | $163.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,211.37 | 2019-2025 | Clareon, Precision7, Centurion |
| Johnson & Johnson Vision Care, INC. | $586.84 | 2019-2025 | Acuvue |
| New World Medical,INC. | $363.36 | 2022-2025 | Clearpath, Via360, Streamline |
| Bausch & Lomb Americas INC. | $247.88 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Biotissue Holdings INC. | $239.99 | 2023-2025 | |
| Glaukos Corporation | $221.58 | 2019-2022 | |
| Abbvie INC. | $193.42 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $173.27 | 2019-2021 | |
| Optos, INC. | $163.93 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Astellas Pharma US INC | $160.31 | 2023 | Izervay |
| Allergan, INC. | $155.01 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $120.00 | 2019 | |
| Avedro INC. | $106.69 | 2019 | |
| Dompe US, INC. | $87.23 | 2024 | Oxervate |
| Sight Sciences, INC. | $82.10 | 2025 | Tearcare System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $53.91 | 2023 | Cequa |
| Hu-Friedy Mfg. Co., LLC | $43.45 | 2019 | |
| Thea Pharma INC. | $40.72 | 2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $35.88 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.79 | 2020 | |
| Harrow Eye, LLC | $29.21 | 2025 | Vevye |
| Coopervision INC. | $28.70 | 2019-2025 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.